Heterozygous carriers of mutationsin the cystic fibrosis transmembrane regulator (CFTR) geneare predisposed to idiopathic chronic pancreatitis (Weiss etal., 2005) and chronic obstructive pulmonary disease (Divacet al., 2004). This evidence concerns the gene CFTR and chronic obstructive pulmonary disease.